Unlocking the Hidden Potential of Competitive Intelligence in Pharma

Approx.
1 min read
Caption:
First Published: 
May 2012
Updated: 

An interesting article in PharmaVoice in April 2012 – regarding Competitive Intelligence and Competitor Strategy.  The article rightly points out that Pharma is leaving good intel on the table –by not developing relationships and using them effectively; or by taking a very high-minded attitude to informal sources of intel (e.g. conversations overheard at airports); or with a short-term approach that means that work is lost to the rest of the company as the product moves along the development path.

While we can’t help our clients make their relationships work better or assist them in eavesdropping, we can help them ensure that useful competitor intelligence is synthesised and stored during the development process, so that by the time the product is in a late stage the company has a bank of tiered, high quality, objectively assessed information in an interactive filterable format. Allowing rapid and reliable comparison between competitor attributes, claims, evidence bases and future research.

Contact info@rxcomms.com for more information.

Competitive Intelligence in pharma

Competitor strategy in pharma

Data synthesis

Competitor data synthesis

We'll deliver straight to your inbox

We take your privacy very seriously and will never share your details with other parties.
You're subscribed! We'll send you a welcome email shortly, keep an eye out and if you don't find it perhaps check the (sometimes over-zealous) spam folder.
Oops! Something went wrong while submitting the form.
Ruth Whittington
CEO of Rx Values Group Ltd
MSc(hons), NZSRN
Share this post

Discover the Power of Communication with Rx

Embark on your medcomms journey with Rx today and experience the difference of working with a world-class medical communications agency.

Child playing in autumn leaves
Copyright Rx Communications Ltd